Holding(s) in Company

Sinclair Pharma plc (the "Company")

The Company was informed on 12 April 2010 that following the conversion of warrants over 2,348,500 ordinary shares of 1p each ("Ordinary Shares") Michael Flynn and his associated parties are interested in a total of 14,149,395 Ordinary Shares, representing approximately 8.73 per cent. of the Company's issued share capital.

For further information please contact:

Sinclair Pharma plc Tel: +44 (0) 1483 410 600

Alan Olby, CFO

Singer Capital Markets Ltd Tel: +44 (0)20 3205 7500

Shaun Dobson

Claes Spång